BridgeMD
New treatment option for Malaria
Official title Seasonal R21 Mass Vaccination for Malaria Elimination
ClinicalTrials.gov ID: NCT06578572
What this study is testing
What is R21Matrix M?
R21Matrix M is an investigational medicine, given as a monthly, being studied as a potential treatment for malaria.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This is a cluster randomized trial to determine the impact of seasonal R21/MM mass vaccination (all ages) on malaria transmission and morbidity. Fifty-four villages (30 in The Gambia and 24 in Burkina Faso) will be randomized to either mass vaccination with R21 or no mass vaccination.
- Phase 3: a large, late-stage study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 5 to 99. Healthy volunteers may be eligible.
You may be able to join if
- Age≥ 5 months.
- Willingness to comply with trial procedures.
- Individual written informed consent obtained at the beginning of the study.
You likely can't join if
- Pregnancy
- History of allergic disease or reactions likely to be exacerbated by any component of the vaccines, e.g., Kathon, neomycin, betapropiolactone.
- Any history of anaphylaxis in relation to vaccination.
- Known chronic illness.
- Any other significant disease, disorder or situation which, in the opinion of the Investigator, may either put the participants at risk because of...
The study team makes the final eligibility decision.
Where it's taking place
- Nanoro, Burkina Faso
- Fajara, The Gambia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 5 months to 99 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nanoro, Burkina Faso; Fajara, The Gambia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.